KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Recursion Pharmaceuticals (RXRX) Goodwill & Intangibles (2020 - 2025)

Recursion Pharmaceuticals (RXRX) has disclosed Goodwill & Intangibles for 6 consecutive years, with $162.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Goodwill & Intangibles changed N/A year-over-year to $162.0 million, compared with a TTM value of $162.0 million through Sep 2025, changed N/A, and an annual FY2024 reading of $484.7 million, up 447.72% over the prior year.
  • Goodwill & Intangibles was $162.0 million for Q3 2025 at Recursion Pharmaceuticals, down from $341.3 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $484.7 million in Q4 2024 and bottomed at $1.5 million in Q3 2022.
  • Average Goodwill & Intangibles over 5 years is $113.4 million, with a median of $2.4 million recorded in 2021.
  • The sharpest move saw Goodwill & Intangibles crashed 35.59% in 2022, then skyrocketed 4100.24% in 2023.
  • Year by year, Goodwill & Intangibles stood at $2.2 million in 2021, then dropped by 3.61% to $2.1 million in 2022, then surged by 4100.24% to $88.5 million in 2023, then skyrocketed by 447.72% to $484.7 million in 2024, then crashed by 66.57% to $162.0 million in 2025.
  • Business Quant data shows Goodwill & Intangibles for RXRX at $162.0 million in Q3 2025, $341.3 million in Q2 2025, and $158.1 million in Q1 2025.